| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer
|
Li, Jun
|
|
2010
|
119 |
3 |
p. 543-548
6 p.
|
artikel
|
| 2 |
Biological role and prognostic significance of NAC1 in ovarian cancer
|
Nakayama, Kentaro
|
|
2010
|
119 |
3 |
p. 469-478
10 p.
|
artikel
|
| 3 |
Correlates of the preoperative level of CA125 at presentation of ovarian cancer
|
Cramer, Daniel W.
|
|
2010
|
119 |
3 |
p. 462-468
7 p.
|
artikel
|
| 4 |
Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor
|
Wang, Fengjun
|
|
2010
|
119 |
3 |
p. 586-593
8 p.
|
artikel
|
| 5 |
Corrigendum to “Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer” [Gynecologic Oncology 111 (2008) 461–466]
|
Richardson, Debra L.
|
|
2010
|
119 |
3 |
p. 603-
1 p.
|
artikel
|
| 6 |
Corrigendum to “Creation and characterization of a xenograft model for human cervical cancer” [Gynecologic Oncology 118 (2010) 76–80]
|
Hoffmann, Corinna
|
|
2010
|
119 |
3 |
p. 604-
1 p.
|
artikel
|
| 7 |
Distribution of human papillomavirus 58 and 52 E6/E7 variants in cervical neoplasia in Chinese women
|
Ding, Tian
|
|
2010
|
119 |
3 |
p. 436-443
8 p.
|
artikel
|
| 8 |
Dose escalation and pharmacokinetic study of AEZS-108 (AN-152), an LHRH agonist linked to doxorubicin, in women with LHRH receptor-positive tumors
|
Emons, Günter
|
|
2010
|
119 |
3 |
p. 457-461
5 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2010
|
119 |
3 |
p. i-
1 p.
|
artikel
|
| 10 |
Endometrial effects of exemestane compared to tamoxifen within the Tamoxifen Exemestane Adjuvant Multicenter (TEAM) trial: Results of a prospective gynecological ultrasound substudy
|
Kieback, D.G.
|
|
2010
|
119 |
3 |
p. 500-505
6 p.
|
artikel
|
| 11 |
Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment
|
Blank, Stephanie V.
|
|
2010
|
119 |
3 |
p. 451-456
6 p.
|
artikel
|
| 12 |
Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells
|
Taylor-Harding, Barbie
|
|
2010
|
119 |
3 |
p. 549-556
8 p.
|
artikel
|
| 13 |
Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: A Gynecologic Oncology Group study
|
Cella, David
|
|
2010
|
119 |
3 |
p. 531-537
7 p.
|
artikel
|
| 14 |
Hybrid imaging by SPECT/CT for sentinel lymph node detection in patients with cancer of the uterine cervix
|
Martínez, A.
|
|
2010
|
119 |
3 |
p. 431-435
5 p.
|
artikel
|
| 15 |
Identification of a patient group at low risk for parametrial invasion in early-stage cervical cancer
|
Jung, Dae-Chul
|
|
2010
|
119 |
3 |
p. 426-430
5 p.
|
artikel
|
| 16 |
Immunization with synthetic VEGF peptides in ovarian cancer
|
Wang, Bing
|
|
2010
|
119 |
3 |
p. 564-570
7 p.
|
artikel
|
| 17 |
Kisspeptin-10 inhibits bone-directed migration of GPR54-positive breast cancer cells: Evidence for a dose–window effect
|
Olbrich, Teresa
|
|
2010
|
119 |
3 |
p. 571-578
8 p.
|
artikel
|
| 18 |
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery
|
Ferrandina, G.
|
|
2010
|
119 |
3 |
p. 404-410
7 p.
|
artikel
|
| 19 |
Micrometastasis of endometrial cancer to sentinel lymph nodes: Is it an artifact of uterine manipulation?
|
Frimer, Marina
|
|
2010
|
119 |
3 |
p. 496-499
4 p.
|
artikel
|
| 20 |
New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis
|
van der Steen, S.
|
|
2010
|
119 |
3 |
p. 520-525
6 p.
|
artikel
|
| 21 |
Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184
|
Cella, David
|
|
2010
|
119 |
3 |
p. 538-542
5 p.
|
artikel
|
| 22 |
Postoperative radiotherapy use and patterns of care analysis for node positive or parametria positive cervical cancer
|
Ghia, Amol J.
|
|
2010
|
119 |
3 |
p. 411-416
6 p.
|
artikel
|
| 23 |
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer
|
Han, Ernest S.
|
|
2010
|
119 |
3 |
p. 484-490
7 p.
|
artikel
|
| 24 |
Predictive factors for prolonged survival in recurrent endometrial carcinoma: Implications for follow-up protocol
|
Otsuka, Isao
|
|
2010
|
119 |
3 |
p. 506-510
5 p.
|
artikel
|
| 25 |
Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: A Southwest Oncology Group Study
|
Randall, Leslie M.
|
|
2010
|
119 |
3 |
p. 417-421
5 p.
|
artikel
|
| 26 |
PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma
|
Pavlakis, Kitty
|
|
2010
|
119 |
3 |
p. 516-519
4 p.
|
artikel
|
| 27 |
Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study
|
Hurteau, Jean A.
|
|
2010
|
119 |
3 |
p. 444-450
7 p.
|
artikel
|
| 28 |
Rapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: A search for biomarkers of sensitivity to treatment
|
Bae-Jump, Victoria L.
|
|
2010
|
119 |
3 |
p. 579-585
7 p.
|
artikel
|
| 29 |
Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer
|
Zand, Behrouz
|
|
2010
|
119 |
3 |
p. 422-425
4 p.
|
artikel
|
| 30 |
Response to: “What is the role of neoadjuvant chemotherapy in advanced endometrial cancer?”
|
Barlin, Joyce N.
|
|
2010
|
119 |
3 |
p. 601-602
2 p.
|
artikel
|
| 31 |
Simple or complex: Optimal therapy for cancer of the cervix
|
Gaffney, David K
|
|
2010
|
119 |
3 |
p. 401-403
3 p.
|
artikel
|
| 32 |
Suberoylanilide hydroxamic acid partly reverses resistance to paclitaxel in human ovarian cancer cell lines
|
Angelucci, Adriano
|
|
2010
|
119 |
3 |
p. 557-563
7 p.
|
artikel
|
| 33 |
The anterior Obturator Artery Perforator (aOAP) flap: Surgical anatomy and application of a method for vulvar reconstruction
|
O'Dey, Dan mon
|
|
2010
|
119 |
3 |
p. 526-530
5 p.
|
artikel
|
| 34 |
The effect of age on the tolerability of intraperitoneal chemotherapy, complication rate, and survival in patients with ovarian cancer
|
Kothari, Rajul
|
|
2010
|
119 |
3 |
p. 491-495
5 p.
|
artikel
|
| 35 |
The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients
|
Barak, Frida
|
|
2010
|
119 |
3 |
p. 511-515
5 p.
|
artikel
|
| 36 |
Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model
|
Van Calsteren, K.
|
|
2010
|
119 |
3 |
p. 594-600
7 p.
|
artikel
|
| 37 |
Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival
|
Lose, Felicity
|
|
2010
|
119 |
3 |
p. 479-483
5 p.
|
artikel
|
| 38 |
What is the role of neoadjuvant chemotherapy in advanced endometrial cancer?
|
Amant, Frédéric
|
|
2010
|
119 |
3 |
p. 601-
1 p.
|
artikel
|
Tijdschrift beschrijving